Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes: a Multicenter Cohort Study

NCT04017221 is registered in ClinicalTrials.gov with Canadian Network for Observational Drug Effect Studies, CNODES as lead sponsor.

NCT NCT04017221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04017221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes: a Multicenter Cohort Study
Lead sponsor
Canadian Network for Observational Drug Effect Studies, CNODES
Phase
Observational
Overall status
Completed
Start date
October 1, 2018
Completion date
December 1, 2019
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, diabetic ketoacidosis, lower extremity amputation, urosepsis